European Journal of Cancer
Volume 46, Issue 4 , Pages 758-764 , March 2010

Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis

  • Yadong Wang

      Affiliations

    • Henan Center for Disease Control and Prevention, Zhengzhou 450016, PR China
    • Corresponding Author InformationCorresponding author: Tel.: +86 371 68089043; fax: +86 371 68089042.
    • ,
  • Haiyan Yang

      Affiliations

    • Department of Epidemiology and Health Statistics, School of Public Health, Zhengzhou University, Zhengzhou 450001, PR China
    • ,
  • Li Li

      Affiliations

    • Henan Center for Disease Control and Prevention, Zhengzhou 450016, PR China
    • ,
  • Haiyu Wang

      Affiliations

    • Henan Center for Disease Control and Prevention, Zhengzhou 450016, PR China
    • ,
  • Congke Zhang

      Affiliations

    • Henan Center for Disease Control and Prevention, Zhengzhou 450016, PR China
    • ,
  • Gongju Yin

      Affiliations

    • Henan Center for Disease Control and Prevention, Zhengzhou 450016, PR China
    • ,
  • Baoyu Zhu

      Affiliations

    • Henan Center for Disease Control and Prevention, Zhengzhou 450016, PR China

Received 15 September 2009 ,Accepted 2 December 2009.

Reference 

  1. Voicu-Maceseanu A, Nitu M, Olteanu M, Bica D. Epidemiology of lung cancer. Pneumologia. 2007;56(2):78–84
  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–249
  3. Cote ML, Chen W, Smith DW, et al. Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2009;169(7):802–814
  4. Schabath MB, Spitz MR, Hong WK, et al. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung cancer. 2002;37(1):35–40
  5. Kiyohara C, Yoshimasu K, Shirakawa T, Hopkin JM. Genetic polymorphisms and environmental risk of lung cancer: a review. Rev Environ Health. 2004;19(1):15–38
  6. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol. 2000;18(11):2309–2315
  7. Shah PP, Singh AP, Singh M, et al. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res. 2008;639(1–2):1–10
  8. Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab. 2008;9(6):520–531
  9. Carlsten C, Sagoo GS, Frodsham AJ, Burke W, Higgins JP. Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol. 2008;167(7):759–774
  10. Raimondi S, Paracchini V, Autrup H, et al. Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. Am J Epidemiol. 2006;164(11):1027–1042
  11. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med. 2005;7(7):463–478
  12. Le Marchand L, Guo C, Benhamou S, et al. Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control. 2003;14(4):339–346
  13. Liu Y, Meng XW, Zhou LY, Zhang PY, Sun X, Zhang P. Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. Hepatobiliary Pancreat Dis Int. 2009;8(2):162–167
  14. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5’-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991;110(4):559–565
  15. Oyama T, Kawamoto T, Mizoue T, et al. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res. 1997;17(1B):583–587
  16. Uematsu F, Kikuchi H, Motomiya M, et al. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res. 1991;82(3):254–256
  17. Hirvonen A, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Vainio H. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis. 1993;14(1):85–88
  18. Watanabe J, Yang JP, Eguchi H, et al. An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res. 1995;86(3):245–248
  19. London SJ, Daly AK, Cooper J, et al. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics. 1996;6(2):151–158
  20. Kato S, Shields PG, Caporaso NE, et al. Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res. 1992;52(23):6712–6715
  21. Wu X, Shi H, Jiang H, et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 1997;18(5):967–973
  22. Marchand LL, Wilkinson GR, Wilkens LR. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev. 1999;8(6):495–500
  23. Minegishi Y, Tsukino H, Muto M, et al. Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population. Cancer. 2007;110(2):353–362
  24. Lee KM, Kang D, Lee SJ, et al. Interactive effect of genetic polymorphism of glutathione S-transferase M1 and smoking on squamous cell lung cancer risk in Korea. Oncol Rep. 2006;16(5):1035–1039
  25. Hamada GS, Sugimura H, Suzuki I, et al. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev. 1995;4(1):63–67
  26. Shi Y, Zhou X, Zhou Y, Ren X. Analysis of CYP2E1, GSTM1 Genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Technol (Health Science). 2002;31(1):14–17
  27. Ye W, Chen S, Chen Q, Zhang D, Cai X. Association of CYP2E1 polymorphism and serum selenium level with risk of human lung cancer. Tumor. 2006;26(5):450–452
  28. Zou L, Lv B, Zhang X, Zhou S, Hao Q, Zhou Y. Effect of CYP2E1 Polymorphism on DNA Stability and Lung Cancer Susceptibility. J Environ Occup Med. 2004;21(2):81–83
  29. Chen S, Yu S, Chen Q, et al. A case-control study of the impact of CYP2E1 RsaI polymorphism on the risk of lung cancer. J Guangdong College Pharm. 2002;18(3):220–224
  30. Li D, Zhou Q, Guo Z, et al. Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility:a case control study. Acta Academiae Medicinae Militaris Tertiae. 2008;30(13):1231–1234
  31. Huang Y, Wang Q, Zhu L, Zhang Y. Relationship between cytochrome P450 2E1 genetic polymorphism and lung cancer in Chinese Han subjects. Chin J Clin Pharmacol. 2000;16(5):350–352
  32. Li Z, Tan W, Shao K, Zhang L, Lin D. Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1. Chin J Oncol. 2000;22(1):5–7
  33. Qu Y, Shi Y, Zhang L, et al. Cytochrome P450 2E1 genetic polymorphism and non-smoking female lung cancer risk. Carcinog Teratogenesis Mutagen. 1998;10(6):355–358
  34. Li W, Lai B, Zhan X. The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer. Chin J Epidemiol. 2004;25(12):1042–1045
  35. Quinones L, Lucas D, Godoy J, et al. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 2001;174(1):35–44
  36. Wang SL, Lee H, Chen KW, Tsai KJ, Chen CY, Lin P. Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung cancer. 1999;26(1):27–34
  37. Wang J, Deng Y, Li L, et al. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci. 2003;94(5):448–452
  38. Oyama T, Matsumoto A, Isse T, et al. Evidence-based prevention (EBP): approach to lung cancer prevention based on cytochrome 1A1 and cytochrome 2E1 polymorphism. Anticancer Res. 2003;23(2C):1731–1737
  39. Persson I, Johansson I, Bergling H, et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett. 1993;319(3):207–211
  40. Persson I, Johansson I, Lou YC, et al. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer. 1999;81(3):325–329
  41. El-Zein RA, Zwischenberger JB, Abdel-Rahman SZ, Sankar AB, Au WW. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett. 1997;112(1):71–78
  42. Gu Y, Zhang Z, Zhang S, Zheng S, Jia H, Gu S. Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility. Zhonghua Yi Xue Za Zhi. 2007;87(43):3064–3068
  43. Eom SY, Zhang YW, Kim SH, et al. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control. 2009;20(2):137–145
  44. Kato S, Shields PG, Caporaso NE, et al. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer. Cancer Epidemiol Biomarkers Prev. 1994;3(6):515–518
  45. Le Marchand L, Sivaraman L, Pierce L, et al. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res. 1998;58(21):4858–4863
  46. Wu X, Amos CI, Kemp BL, et al. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998;7(1):13–18
  47. Uematsu F, Kikuchi H, Motomiya M, et al. Human cytochrome P450IIE1 gene: DraI polymorphism and susceptibility to cancer. Tohoku J Exp Med. 1992;168(2):113–117
  48. Liang G, Pu Y, Yin L. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Hereditas. 2004;26(5):584–588
  49. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188
  50. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629–634
  51. Shi X, Zhou S, Wang Z, Zhou Z, Wang Z. CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer. 2008;59(2):155–163
  52. Watanabe J, Hayashi S, Nakachi K, et al. PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res. 1990;18(23):7194
  53. Tan W, Wu J, Tang H, Lin D. Expression of cytochrome P4502E1 in human liver: Relationship between genotype and phenotype in Chinese. Sci China C Life Sci. 2001;44(4):356–364
  54. Lucas D, Menez C, Girre C, et al. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics. 1995;5(5):298–304
  55. Broeks A, Urbanus JH, Floore AN, et al. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet. 2000;66(2):494–500

PII: S0959-8049(09)00922-8

doi: 10.1016/j.ejca.2009.12.010

European Journal of Cancer
Volume 46, Issue 4 , Pages 758-764 , March 2010

Article Tools